Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Funds / FCA Health Innovations III QP, LP

FCA Health Innovations III QP, LP

FundraisingActive offering evidenceFeeder or parallelADV: Venture Capital FundFCA Management Group, LLCDelaware
Amounts, each with its basis
Vintage
2026basis: form d first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$175Mwhat may be sold, not what was raised; file 021-584293, sworn by the adviser or filed under this vehicle
Form D sold
$49.9Mas of the filing of May 15, 2026, 85 investors
First sale
Apr 30, 2026
Reported GAV
$49.9Mon the Form ADV filed Sep 14, 2026; the fund's assets, never its size or dry powder
Owners (ADV)
85
Reported on ADV
Sep 12, 2026 to Sep 14, 2026
Fundraising evidence
Active offering evidence
Form D filed or amended 2026-05-15: sold $49.9M of a stated $175.0M offering (fr-1)
evidence dated May 15, 2026. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Fundraising
Form D within 18 months and the offering is not sold out
first sale: 2026-04-30vintage year: $2,026adv gav as of: 2026-09-14vintage basis: form_d_first_saleform d sold usd: $49.9Mform d offering usd: $175Mform d latest filed at: 2026-05-15
The fund's own reporting through time
1 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Sep 14, 2026Venture Capital Fund$49.9M
85$250,0002%
Principals and agents
7 principals on Form D, 0 placement agents
  • Andrew J. Bouldin Executive Officer
  • Charles W Johnson Executive Officer
  • . A. FCA Health Innovations III SLP, LLC Executive Officer
  • . A. FCA Health Innovations III GP, LLC Executive Officer
  • Matthew a King Executive Officer
  • Whitney H Kalb Executive Officer
  • FCA Health Innovations III GP LLC general partner (ADV 7.B.(1).A.3)
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
1 events
  1. May 15, 2026
    FCA Health Innovations III QP, LP filed Form D: $49,875,000 sold of $175,000,000, Venture Capital Fund
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
17 observations
Every observation on this vehicle